If all radioactivity is excreted, the patient is unable to absorb B12, while a low fecal excretion of the radioactive B12 indicates that some of the vitamin has been absorbed
This helps your body take in the medicine better
Retatrutide is an investigational triple incretin receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors, producing appetite suppression, enhanced insulin secretion, and increased energy expenditure, though long-term safety and cardiovascular outcome data are not yet available
These include whole blood, serum, plasma (EDTA and Heparin), erythrocytes, urine, cell lysates, and tissue